Knowledge Center

Article / Sep 23, 2014

Quality Metrics - A Case for an FDA Dean's List

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology, September 2014

The author (Guy Villax)Ìýpresents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

  • Read the extendedÌýversion with links to references, examples and case studiesÌý
  • Read the article in Pharmaceutical TechnologyÌýÌý

Ìý

Also in the Knowledge Center

Related Content

ËÄÉ«AV Policies

ËÄÉ«AV is dedicated to serving the Pharma Industry by providing services and products that save human lives and improve quality of life. Our team is fully committed to our Quality, HSEEn, HR and Innovation & Entrepreneurship policies.

Page
Read more

Nanoparticles

At ËÄÉ«AV we have both top-down and bottom-up technologies to produce pharmaceutical nanoparticles for oral delivery.

Page
Read more

Contact Us

Page
Read more